Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001493152-25-029621
Filing Date
2025-12-30
Accepted
2025-12-30 16:30:27
Documents
1
Period of Report
2025-12-30

Document Format Files

Seq Description Document Type Size
1 DEF 14C formdef14c.htm DEF 14C 175597
  Complete submission text file 0001493152-25-029621.txt   176665
Mailing Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084
Business Address 1400 BROADFIELD BLVD. SUITE 130 HOUSTON TX 77084 585 232 1500
IMPACT BIOMEDICAL INC. (Filer) CIK: 0001834105 (see all company filings)

EIN.: 853926944 | State of Incorp.: NV | Fiscal Year End: 1231
Type: DEF 14C | Act: 34 | File No.: 001-42212 | Film No.: 251614679
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)